A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma
Open Access
- 15 December 2021
- journal article
- research article
- Published by Acta Naturae Ltd in Acta Naturae
- Vol. 13 (4) , 47-52
Abstract
Elevated levels of apoB-100 containing lipoproteins and markers of systemic inflammation are often observed in patients with cardiovascular diseases. The concentrations can be reduced by pharmacotherapy or extracorporeal treatment. The sorbent, which removes CRP and atherogenic lipoproteins, simultaneously reduces the bloodstream concentration of these components. The efficacy and selectivity of the designed sorbent were studied, desorption constants of CRP (Kd = 4.2 10-8 M) and LDL (Kd = 7.7 10-7 M) were distribution coefficients of CRP (Kc = 101) and Lp(a) (Kc = 38) were calculated, and the ability to bind large amounts of atherogenic lipoproteins (up to 32 mg of TC per mL of the sorbent gel) was demonstrated. Our sorbent can be recommended for performing complex removal of CRP and atherogenic lipoproteins from the blood plasma in patients with refractory hyperlipidemia and CVD that are accompanied by elevated levels of CRP.Keywords
This publication has 33 references indexed in Scilit:
- Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of AtherosclerosisClinical Chemistry, 2016
- Increased monomeric CRP levels in acute myocardial infarction: A possible new and specific biomarker for diagnosis and severity assessment of diseaseAtherosclerosis, 2015
- Аффинные гемосорбенты на основе ароматических пептидов для связывания иммуноглобулинов класса GБиоорганическая химия, 2015
- Selective apheresis of C-reactive protein: A new therapeutic option in myocardial infarction?Journal of Clinical Apheresis, 2014
- Dissociation of Pentameric to Monomeric C-Reactive Protein Localizes and Aggravates InflammationCirculation, 2014
- Healthy Lifestyle Change and Subclinical Atherosclerosis in Young AdultsCirculation, 2014
- LOX-1, OxLDL, and AtherosclerosisMediators of Inflammation, 2013
- Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarctionJournal of Clinical Pathology, 2006
- Altered metabolism and mitochondrial genome in prostate cancerJournal of Clinical Pathology, 2006
- Enzyme immunoassay of lipoprotein(a)Bulletin of Experimental Biology and Medicine, 1995